1 Market Overview

1.1 Product Overview and Scope of Enteric Disease Testing and Therapeutic

1.2 Classification of Enteric Disease Testing and Therapeutic by Type

1.2.1 Overview: Global Enteric Disease Testing and Therapeutic Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type in 2020

1.2.3 Bacterial disease

1.2.4 Viral disease

1.2.5 Parasitic diseases

1.3 Global Enteric Disease Testing and Therapeutic Market by Application

1.3.1 Overview: Global Enteric Disease Testing and Therapeutic Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital

1.3.3 Research

1.4 Global Enteric Disease Testing and Therapeutic Market Size & Forecast

1.5 Global Enteric Disease Testing and Therapeutic Market Size and Forecast by Region

1.5.1 Global Enteric Disease Testing and Therapeutic Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Enteric Disease Testing and Therapeutic Market Size by Region, (2016-2021)

1.5.3 North America Enteric Disease Testing and Therapeutic Market Size and Prospect (2016-2026)

1.5.4 Europe Enteric Disease Testing and Therapeutic Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size and Prospect (2016-2026)

1.5.6 South America Enteric Disease Testing and Therapeutic Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Enteric Disease Testing and Therapeutic Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Enteric Disease Testing and Therapeutic Market Drivers

1.6.2 Enteric Disease Testing and Therapeutic Market Restraints

1.6.3 Enteric Disease Testing and Therapeutic Trends Analysis

2 Company Profiles

2.1 Abbott

2.1.1 Abbott Details

2.1.2 Abbott Major Business

2.1.3 Abbott Enteric Disease Testing and Therapeutic Product and Solutions

2.1.4 Abbott Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Abbott Recent Developments and Future Plans

2.2 GlaxoSmithKline

2.2.1 GlaxoSmithKline Details

2.2.2 GlaxoSmithKline Major Business

2.2.3 GlaxoSmithKline Enteric Disease Testing and Therapeutic Product and Solutions

2.2.4 GlaxoSmithKline Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 GlaxoSmithKline Recent Developments and Future Plans

2.3 Becton Dickinson

2.3.1 Becton Dickinson Details

2.3.2 Becton Dickinson Major Business

2.3.3 Becton Dickinson Enteric Disease Testing and Therapeutic Product and Solutions

2.3.4 Becton Dickinson Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Becton Dickinson Recent Developments and Future Plans

2.4 bioMérieux

2.4.1 bioMérieux Details

2.4.2 bioMérieux Major Business

2.4.3 bioMérieux Enteric Disease Testing and Therapeutic Product and Solutions

2.4.4 bioMérieux Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 bioMérieux Recent Developments and Future Plans

2.5 Sanofi

2.5.1 Sanofi Details

2.5.2 Sanofi Major Business

2.5.3 Sanofi Enteric Disease Testing and Therapeutic Product and Solutions

2.5.4 Sanofi Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Sanofi Recent Developments and Future Plans

2.6 Bayer Pharma

2.6.1 Bayer Pharma Details

2.6.2 Bayer Pharma Major Business

2.6.3 Bayer Pharma Enteric Disease Testing and Therapeutic Product and Solutions

2.6.4 Bayer Pharma Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Bayer Pharma Recent Developments and Future Plans

2.7 Bio-Rad

2.7.1 Bio-Rad Details

2.7.2 Bio-Rad Major Business

2.7.3 Bio-Rad Enteric Disease Testing and Therapeutic Product and Solutions

2.7.4 Bio-Rad Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Bio-Rad Recent Developments and Future Plans

2.8 Quest Diagnostics

2.8.1 Quest Diagnostics Details

2.8.2 Quest Diagnostics Major Business

2.8.3 Quest Diagnostics Enteric Disease Testing and Therapeutic Product and Solutions

2.8.4 Quest Diagnostics Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Quest Diagnostics Recent Developments and Future Plans

2.9 Trinity Biotech

2.9.1 Trinity Biotech Details

2.9.2 Trinity Biotech Major Business

2.9.3 Trinity Biotech Enteric Disease Testing and Therapeutic Product and Solutions

2.9.4 Trinity Biotech Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Trinity Biotech Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Enteric Disease Testing and Therapeutic Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 5 Enteric Disease Testing and Therapeutic Players Market Share

3.2.2 Top 10 Enteric Disease Testing and Therapeutic Players Market Share

3.2.3 Market Competition Trend

3.3 Enteric Disease Testing and Therapeutic Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Enteric Disease Testing and Therapeutic Revenue and Market Share by Type (2016-2021)

4.2 Global Enteric Disease Testing and Therapeutic Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2016-2021)

5.2 Enteric Disease Testing and Therapeutic Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Enteric Disease Testing and Therapeutic Revenue by Type (2016-2026)

6.2 North America Enteric Disease Testing and Therapeutic Revenue by Application (2016-2026)

6.3 North America Enteric Disease Testing and Therapeutic Market Size by Country

6.3.1 North America Enteric Disease Testing and Therapeutic Revenue by Country (2016-2026)

6.3.2 United States Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

6.3.3 Canada Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

6.3.4 Mexico Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Enteric Disease Testing and Therapeutic Revenue by Type (2016-2026)

7.2 Europe Enteric Disease Testing and Therapeutic Revenue by Application (2016-2026)

7.3 Europe Enteric Disease Testing and Therapeutic Market Size by Country

7.3.1 Europe Enteric Disease Testing and Therapeutic Revenue by Country (2016-2026)

7.3.2 Germany Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

7.3.3 France Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

7.3.5 Russia Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

7.3.6 Italy Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Enteric Disease Testing and Therapeutic Revenue by Type (2016-2026)

8.2 Asia-Pacific Enteric Disease Testing and Therapeutic Revenue by Application (2016-2026)

8.3 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region

8.3.1 Asia-Pacific Enteric Disease Testing and Therapeutic Revenue by Region (2016-2026)

8.3.2 China Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

8.3.3 Japan Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

8.3.4 South Korea Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

8.3.5 India Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

8.3.7 Australia Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Enteric Disease Testing and Therapeutic Revenue by Type (2016-2026)

9.2 South America Enteric Disease Testing and Therapeutic Revenue by Application (2016-2026)

9.3 South America Enteric Disease Testing and Therapeutic Market Size by Country

9.3.1 South America Enteric Disease Testing and Therapeutic Revenue by Country (2016-2026)

9.3.2 Brazil Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

9.3.3 Argentina Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Enteric Disease Testing and Therapeutic Revenue by Type (2016-2026)

10.2 Middle East & Africa Enteric Disease Testing and Therapeutic Revenue by Application (2016-2026)

10.3 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country

10.3.1 Middle East & Africa Enteric Disease Testing and Therapeutic Revenue by Country (2016-2026)

10.3.2 Turkey Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

10.3.4 UAE Enteric Disease Testing and Therapeutic Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Enteric Disease Testing and Therapeutic Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Enteric Disease Testing and Therapeutic Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Enteric Disease Testing and Therapeutic Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Enteric Disease Testing and Therapeutic Revenue (USD Million) by Region (2016-2021)

Table 5. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Region (2021-2026)

Table 6. Abbott Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Major Business

Table 8. Abbott Enteric Disease Testing and Therapeutic Product and Solutions

Table 9. Abbott Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 11. GlaxoSmithKline Major Business

Table 12. GlaxoSmithKline Enteric Disease Testing and Therapeutic Product and Solutions

Table 13. GlaxoSmithKline Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Becton Dickinson Corporate Information, Head Office, and Major Competitors

Table 15. Becton Dickinson Major Business

Table 16. Becton Dickinson Enteric Disease Testing and Therapeutic Product and Solutions

Table 17. Becton Dickinson Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. bioMérieux Corporate Information, Head Office, and Major Competitors

Table 19. bioMérieux Major Business

Table 20. bioMérieux Enteric Disease Testing and Therapeutic Product and Solutions

Table 21. bioMérieux Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Sanofi Corporate Information, Head Office, and Major Competitors

Table 23. Sanofi Major Business

Table 24. Sanofi Enteric Disease Testing and Therapeutic Product and Solutions

Table 25. Sanofi Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Bayer Pharma Corporate Information, Head Office, and Major Competitors

Table 27. Bayer Pharma Major Business

Table 28. Bayer Pharma Enteric Disease Testing and Therapeutic Product and Solutions

Table 29. Bayer Pharma Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Bio-Rad Corporate Information, Head Office, and Major Competitors

Table 31. Bio-Rad Major Business

Table 32. Bio-Rad Enteric Disease Testing and Therapeutic Product and Solutions

Table 33. Bio-Rad Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Quest Diagnostics Corporate Information, Head Office, and Major Competitors

Table 35. Quest Diagnostics Major Business

Table 36. Quest Diagnostics Enteric Disease Testing and Therapeutic Product and Solutions

Table 37. Quest Diagnostics Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Trinity Biotech Corporate Information, Head Office, and Major Competitors

Table 39. Trinity Biotech Major Business

Table 40. Trinity Biotech Enteric Disease Testing and Therapeutic Product and Solutions

Table 41. Trinity Biotech Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Global Enteric Disease Testing and Therapeutic Revenue (USD Million) by Players (2019-2021)

Table 43. Global Enteric Disease Testing and Therapeutic Revenue Share by Players (2019-2021)

Table 44. Breakdown of Enteric Disease Testing and Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3)

Table 45. Enteric Disease Testing and Therapeutic Players Head Office, Products and Services Provided

Table 46. Enteric Disease Testing and Therapeutic Mergers & Acquisitions in the Past Five Years

Table 47. Enteric Disease Testing and Therapeutic New Entrants and Expansion Plans

Table 48. Global Enteric Disease Testing and Therapeutic Revenue (USD Million) by Type (2016-2021)

Table 49. Global Enteric Disease Testing and Therapeutic Revenue Share by Type (2016-2021)

Table 50. Global Enteric Disease Testing and Therapeutic Revenue Forecast by Type (2021-2026)

Table 51. Global Enteric Disease Testing and Therapeutic Revenue by Application (2016-2021)

Table 52. Global Enteric Disease Testing and Therapeutic Revenue Forecast by Application (2021-2026)

Table 53. North America Enteric Disease Testing and Therapeutic Revenue by Type (2016-2021) & (USD Million)

Table 54. North America Enteric Disease Testing and Therapeutic Revenue by Type (2021-2026) & (USD Million)

Table 55. North America Enteric Disease Testing and Therapeutic Revenue by Application (2016-2021) & (USD Million)

Table 56. North America Enteric Disease Testing and Therapeutic Revenue by Application (2021-2026) & (USD Million)

Table 57. North America Enteric Disease Testing and Therapeutic Revenue by Country (2016-2021) & (USD Million)

Table 58. North America Enteric Disease Testing and Therapeutic Revenue by Country (2021-2026) & (USD Million)

Table 59. Europe Enteric Disease Testing and Therapeutic Revenue by Type (2016-2021) & (USD Million)

Table 60. Europe Enteric Disease Testing and Therapeutic Revenue by Type (2021-2026) & (USD Million)

Table 61. Europe Enteric Disease Testing and Therapeutic Revenue by Application (2016-2021) & (USD Million)

Table 62. Europe Enteric Disease Testing and Therapeutic Revenue by Application (2021-2026) & (USD Million)

Table 63. Europe Enteric Disease Testing and Therapeutic Revenue by Country (2016-2021) & (USD Million)

Table 64. Europe Enteric Disease Testing and Therapeutic Revenue by Country (2021-2026) & (USD Million)

Table 65. Asia-Pacific Enteric Disease Testing and Therapeutic Revenue by Type (2016-2021) & (USD Million)

Table 66. Asia-Pacific Enteric Disease Testing and Therapeutic Revenue by Type (2021-2026) & (USD Million)

Table 67. Asia-Pacific Enteric Disease Testing and Therapeutic Revenue by Application (2016-2021) & (USD Million)

Table 68. Asia-Pacific Enteric Disease Testing and Therapeutic Revenue by Application (2021-2026) & (USD Million)

Table 69. Asia-Pacific Enteric Disease Testing and Therapeutic Revenue by Region (2016-2021) & (USD Million)

Table 70. Asia-Pacific Enteric Disease Testing and Therapeutic Revenue by Region (2021-2026) & (USD Million)

Table 71. South America Enteric Disease Testing and Therapeutic Revenue by Type (2016-2021) & (USD Million)

Table 72. South America Enteric Disease Testing and Therapeutic Revenue by Type (2021-2026) & (USD Million)

Table 73. South America Enteric Disease Testing and Therapeutic Revenue by Application (2016-2021) & (USD Million)

Table 74. South America Enteric Disease Testing and Therapeutic Revenue by Application (2021-2026) & (USD Million)

Table 75. South America Enteric Disease Testing and Therapeutic Revenue by Country (2016-2021) & (USD Million)

Table 76. South America Enteric Disease Testing and Therapeutic Revenue by Country (2021-2026) & (USD Million)

Table 77. Middle East & Africa Enteric Disease Testing and Therapeutic Revenue by Type (2016-2021) & (USD Million)

Table 78. Middle East & Africa Enteric Disease Testing and Therapeutic Revenue by Type (2021-2026) & (USD Million)

Table 79. Middle East & Africa Enteric Disease Testing and Therapeutic Revenue by Application (2016-2021) & (USD Million)

Table 80. Middle East & Africa Enteric Disease Testing and Therapeutic Revenue by Application (2021-2026) & (USD Million)

Table 81. Middle East & Africa Enteric Disease Testing and Therapeutic Revenue by Country (2016-2021) & (USD Million)

Table 82. Middle East & Africa Enteric Disease Testing and Therapeutic Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Enteric Disease Testing and Therapeutic Picture

Figure 2. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type in 2020

Figure 3. Bacterial disease

Figure 4. Viral disease

Figure 5. Parasitic diseases

Figure 6. Enteric Disease Testing and Therapeutic Revenue Market Share by Application in 2020

Figure 7. Hospital Picture

Figure 8. Research Picture

Figure 9. Global Enteric Disease Testing and Therapeutic Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Enteric Disease Testing and Therapeutic Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Region (2016-2026)

Figure 12. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Region in 2020

Figure 13. North America Enteric Disease Testing and Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Enteric Disease Testing and Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Enteric Disease Testing and Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Enteric Disease Testing and Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Enteric Disease Testing and Therapeutic Market Drivers

Figure 18. Enteric Disease Testing and Therapeutic Market Restraints

Figure 19. Enteric Disease Testing and Therapeutic Market Trends

Figure 20. Abbott Recent Developments and Future Plans

Figure 21. GlaxoSmithKline Recent Developments and Future Plans

Figure 22. Becton Dickinson Recent Developments and Future Plans

Figure 23. bioMérieux Recent Developments and Future Plans

Figure 24. Sanofi Recent Developments and Future Plans

Figure 25. Bayer Pharma Recent Developments and Future Plans

Figure 26. Bio-Rad Recent Developments and Future Plans

Figure 27. Quest Diagnostics Recent Developments and Future Plans

Figure 28. Trinity Biotech Recent Developments and Future Plans

Figure 30. Global Enteric Disease Testing and Therapeutic Revenue Share by Players in 2020

Figure 31. Enteric Disease Testing and Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 32. Global Top 3 Players Enteric Disease Testing and Therapeutic Revenue Market Share in 2020

Figure 33. Global Top 10 Players Enteric Disease Testing and Therapeutic Revenue Market Share in 2020

Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 35. Global Enteric Disease Testing and Therapeutic Revenue Share by Type in 2020

Figure 36. Global Enteric Disease Testing and Therapeutic Market Share Forecast by Type (2021-2026)

Figure 37. Global Enteric Disease Testing and Therapeutic Revenue Share by Application in 2020

Figure 38. Global Enteric Disease Testing and Therapeutic Market Share Forecast by Application (2021-2026)

Figure 39. North America Enteric Disease Testing and Therapeutic Sales Market Share by Type (2016-2026)

Figure 40. North America Enteric Disease Testing and Therapeutic Sales Market Share by Application (2016-2026)

Figure 41. North America Enteric Disease Testing and Therapeutic Revenue Market Share by Country (2016-2026)

Figure 42. United States Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Canada Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Mexico Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. Europe Enteric Disease Testing and Therapeutic Sales Market Share by Type (2016-2026)

Figure 46. Europe Enteric Disease Testing and Therapeutic Sales Market Share by Application (2016-2026)

Figure 47. Europe Enteric Disease Testing and Therapeutic Revenue Market Share by Country (2016-2026)

Figure 48. Germany Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. France Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. United Kingdom Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Russia Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Italy Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Asia-Pacific Enteric Disease Testing and Therapeutic Sales Market Share by Type (2016-2026)

Figure 54. Asia-Pacific Enteric Disease Testing and Therapeutic Sales Market Share by Application (2016-2026)

Figure 55. Asia-Pacific Enteric Disease Testing and Therapeutic Revenue Market Share by Region (2016-2026)

Figure 56. China Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Japan Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. South Korea Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. India Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Southeast Asia Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Australia Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South America Enteric Disease Testing and Therapeutic Sales Market Share by Type (2016-2026)

Figure 63. South America Enteric Disease Testing and Therapeutic Sales Market Share by Application (2016-2026)

Figure 64. South America Enteric Disease Testing and Therapeutic Revenue Market Share by Country (2016-2026)

Figure 65. Brazil Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Argentina Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Middle East and Africa Enteric Disease Testing and Therapeutic Sales Market Share by Type (2016-2026)

Figure 68. Middle East and Africa Enteric Disease Testing and Therapeutic Sales Market Share by Application (2016-2026)

Figure 69. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue Market Share by Country (2016-2026)

Figure 70. Turkey Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Saudi Arabia Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. UAE Enteric Disease Testing and Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Methodology

Figure 74. Research Process and Data Source